Increased Notch signalling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells

Nature Communications

Volumn 5, Issue , 2014, Pages

  Kwon, Oh Joon ^a   Valdez, Joseph M ^a   Zhang, Li ^a   Zhang, Boyu ^a   Wei, Xing ^a   Su, Qingtai ^a   Ittmann, Michael M ^a,b   Creighton, Chad J ^a   Xin, Li ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR HES 1; ANDROGEN RECEPTOR; BETA CATENIN; CTNNB1 PROTEIN, MOUSE; NOTCH RECEPTOR;

BIOASSAY; CANCER; CELLS AND CELL COMPONENTS; PROTEIN; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION PROFILING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROSTATE LUMINAL EPITHELIAL CELL; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROSTATE; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; ANOIKIS; BETA CATENIN; CELL PROLIFERATION; CELL SURVIVAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROSTATE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANDROGEN; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84907547780     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5416     Document Type: Article

References (70)

1. Abate-Shen, C. & Shen, M. M. Molecular genetics of prostate cancer. Genes Dev. 14, 2410-2434 (2000).
2. Isaacs, J. T. in Benigh Prostatic Hyperplasia (eds Rodgers C. H., C. D. S. & Cunha, G. R.) 85-94 (Bethesda, 1985).
3. Choi, N., Zhang, B., Zhang, L., Ittmann, M. & Xin, L. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 21, 253-265 (2012).
4. Liu, J. et al. Regenerated luminal epithelial cells are derived from preexisting luminal epithelial cells in adult mouse prostate. Mol. Endocrinol. 25, 1849-1857 (2011).
5. Wang, Z. A. et al. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat. Cell. Biol. 15, 274-283 (2013).
6. Lu, T. L. et al. Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice. Am. J. Pathol. 182, 975-991 (2013).
7. Lawson, D. A. & Witte, O. N. Stem cells in prostate cancer initiation and progression. J. Clin. Invest. 117, 2044-2050 (2007).
8. Goldstein, A. S. et al. Purification and direct transformation of epithelial progenitor cells from primary human prostate. Nat. Protoc. 6, 656-667 (2011).
9. Lawson, D. A., Xin, L., Lukacs, R. U., Cheng, D. & Witte, O. N. Isolation and functional characterization of murine prostate stem cells. Proc. Natl Acad. Sci. USA 104, 181-186 (2007).
10. Xin, L., Lawson, D. A. & Witte, O. N. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc. Natl Acad. Sci. USA 102, 6942-6947 (2005).
11. Leong, K. G., Wang, B. E., Johnson, L. & Gao, W. Q. Generation of a prostate from a single adult stem cell. Nature 456, 804-808 (2008).
12. Burger, P. E. et al. Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc. Natl Acad. Sci. USA 102, 7180-7185 (2005).
13. Richardson, G. D. et al. CD133, a novel marker for human prostatic epithelial stem cells. J. Cell. Sci. 117, 3539-3545 (2004).
14. Kwon, O. J., Zhang, L., Ittmann, M. M. & Xin, L. Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin. Proc. Natl Acad. Sci. USA 111, E592-E600 (2014).
15. Xin, L. Cells of origin for cancer: an updated view from prostate cancer. Oncogene 32, 3655-3663 (2013).
16. Salm, S. N. et al. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines. J. Cell. Physiol. 184, 70-79 (2000).
17. Tokar, E. J., Ancrile, B. B., Cunha, G. R. & Webber, M. M. Stem/progenitor and intermediate cell types and the origin of human prostate cancer. Differentiation 73, 463-473 (2005).
18. Frisch, S. M. & Screaton, R. A. Anoikis mechanisms. Curr. Opin. Cell. Biol. 13, 555-562 (2001).
19. McDonnell, T. J. et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52, 6940-6944 (1992).
20. Carroll, D. K. et al. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat. Cell. Biol. 8, 551-561 (2006).
21. Mazzone, M. et al. Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. Proc. Natl Acad. Sci. USA 107, 5012-5017 (2010).
22. Pfohler, C. et al. In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: increased basement membrane gene expression in high-grade and metastatic lesions. Prostate 36, 143-150 (1998).
23. Weaver, V. M. et al. beta4 integrin-dependent formation of polarized threedimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2, 205-216 (2002).
24. Frisch, S. M., Schaller, M. & Cieply, B. Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis. J. Cell. Sci. 126, 21-29 (2013).
25. Zhang, L., Zhao, W., Valdez, J. M., Creighton, C. J. & Xin, L. Low-density Taqman miRNA array reveals miRNAs differentially expressed in prostatic stem cells and luminal cells. Prostate 70, 297-304 (2009).
26. Harper, M. E., Glynne-Jones, E., Goddard, L., Mathews, P. & Nicholson, R. I. Expression of androgen receptor and growth factors in premalignant lesions of the prostate. J. Pathol. 186, 169-177 (1998).
27. Sroka, I. C., McDaniel, K., Nagle, R. B. & Bowden, G. T. Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression. Prostate 68, 463-476 (2008).
28. Kopan, R. & Ilagan, M. X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216-233 (2009).
29. Ang, H. L. & Tergaonkar, V. Notch and NFkappaB signaling pathways: Do they collaborate in normal vertebrate brain development and function? BioEssays 29, 1039-1047 (2007).
30. Mehrotra, S. et al. IAP regulation of metastasis. Cancer Cell 17, 53-64 (2010).
31. Yan, S. R. et al. Activation of NF-kappaB following detachment delays apoptosis in intestinal epithelial cells. Oncogene 24, 6482-6491 (2005).
32. Leong, K. G. et al. Jagged1-mediated Notch activation induces epithelial-tomesenchymal transition through Slug-induced repression of E-cadherin. J. Exp. Med. 204, 2935-2948 (2007).
33. Valdez, J. M. et al. Notch and TGFbeta form a reciprocal positive regulatory loop that suppresses murine prostate basal stem/progenitor cell activity. Cell Stem Cell 11, 676-688 (2012).
34. Park, J. H. et al. Prostatic intraepithelial neoplasia in genetically engineered mice. Am. J. Pathol. 161, 727-735 (2002).
35. Creighton, C. J. Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors. PLoS ONE 3, e1816 (2008).
36. Lavery, D. N. et al. Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors. J. Biol. Chem. 286, 17796-17808 (2011).
37. Belandia, B. et al. Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Mol. Cell. Biol. 25, 1425-1436 (2005).
38. Fujimoto, N., Suzuki, T., Ohta, S. & Kitamura, S. Identification of rat prostatic secreted proteins using mass spectrometric analysis and androgen-dependent mRNA expression. J. Androl. 30, 669-678 (2009).
39. Chen, G. et al. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J. Clin. Invest. 119, 2914-2924 (2009).
40. Noah, T. K., Kazanjian, A., Whitsett, J. & Shroyer, N. F. SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cells. Exp. Cell. Res. 316, 452-465 (2010).
41. Buchwalter, G. et al. PDEF promotes luminal differentiation and acts as a survival factor for er-positive breast cancer cells. Cancer Cell 23, 753-767 (2013).
42. Oettgen, P. et al. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J. Biol. Chem. 275, 1216-1225 (2000).
43. Xin, L., Lukacs, R. U., Lawson, D. A., Cheng, D. & Witte, O. N. Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 25, 2760-2769 (2007).
44. Zhang, L. et al. Targeting CreER(T2) expression to keratin 8-expressing murine simple epithelia using bacterial artificial chromosome transgenesis. Transgenic Res. 21, 1117-1123 (2012).
45. Harada, N. et al. Lack of tumorigenesis in the mouse liver after adenovirusmediated expression of a dominant stable mutant of beta-catenin. Cancer Res. 62, 1971-1977 (2002).
46. Montross, W. T., Ji, H. & McCrea, P. D. A beta-catenin/engrailed chimera selectively suppresses Wnt signaling. J. Cell. Sci. 113(Pt 10): 1759-1770 (2000).
47. Palomero, T. et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat. Med. 13, 1203-1210 (2007).
48. Majumder, P. K. et al. Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc. Natl Acad. Sci. USA 100, 7841-7846 (2003).
49. Mulholland, D. J. et al. Lin-Sca-1+CD49fhigh stem/progenitors are tumorinitiating cells in the Pten-null prostate cancer model. Cancer Res. 69, 8555-8562 (2009).
50. Birbach, A. et al. Persistent inflammation leads to proliferative neoplasia and loss of smooth muscle cells in a prostate tumor model. Neoplasia 13, 692-703 (2011).
51. Ghosh-Choudhury, N., Mandal, C. C., Ghosh-Choudhury, N. & Ghosh Choudhury, G. Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth. Cell Signal. 22, 749-758 (2010).
52. Meng, F., Liu, L., Chin, P. C. & D'Mello, S. R. Akt is a downstream target of NFkappa B. J. Biol. Chem. 277, 29674-29680 (2002).
53. Espinosa, L. et al. The Notch/Hes1 pathway sustains NF-kappaB activation through CYLD repression in T cell leukemia. Cancer Cell 18, 268-281 (2010).
54. Shin, H. M. et al. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J. 25, 129-138 (2006).
55. Cheng, P. et al. Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J. Immunol. 167, 4458-4467 (2001).
56. Vacca, A. et al. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia. EMBO J. 25, 1000-1008 (2006).
57. Shou, J., Ross, S., Koeppen, H., de Sauvage, F. J. & Gao, W. Q. Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res. 61, 7291-7297 (2001).
58. Danza, G. et al. Notch3 is activated by chronic hypoxia and contributes to the progression of human prostate cancer. Int. J. Cancer 133, 2577-2586 (2013).
59. Zhu, H., Zhou, X., Redfield, S., Lewin, J. & Miele, L. Elevated Jagged-1 and Notch-1 expression in high grade and metastatic prostate cancers. Am. J. Transl. Res. 5, 368-378 (2013).
60. Patrawala, L. et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res. 65, 6207-6219 (2005).
61. Domingo-Domenech, J. et al. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumorinitiating cells. Cancer Cell 22, 373-388 (2012).
62. Rajasekhar, V. K., Studer, L., Gerald, W., Socci, N. D. & Scher, H. I. Tumourinitiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling. Nat. Commun. 2, 162 (2011).
63. Wang, X. et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461, 495-500 (2009).
64. Tsujimura, A. et al. Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J. Cell Biol. 157, 1257-1265 (2002).
65. Uzgare, A. R., Xu, Y. & Isaacs, J. T. In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue. J. Cell. Biochem. 91, 196-205 (2004).
66. Gu, G., Yuan, J., Wills, M. & Kasper, S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res. 67, 4807-4815 (2007).
67. Qin, J. et al. The PSA(-/lo) prostate cancer cell population harbors selfrenewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 10, 556-569 (2012).
68. Stoyanova, T. et al. Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells. Proc. Natl Acad. Sci. USA 110, 20111-20116 (2013).
69. De Gendt, K. et al. A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. Proc. Natl Acad. Sci. USA 101, 1327-1332 (2004).
70. Xin, L., Ide, H., Kim, Y., Dubey, P. & Witte, O. N. In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc. Natl Acad. Sci. USA 100(Suppl 1): 11896-11903 (2003).